Hancock Whitney Corp Grows Stake in Axon Enterprise, Inc $AXON

by · The Markets Daily

Hancock Whitney Corp increased its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 7.6% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 424 shares of the biotechnology company’s stock after purchasing an additional 30 shares during the quarter. Hancock Whitney Corp’s holdings in Axon Enterprise were worth $223,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Kentucky Retirement Systems Insurance Trust Fund purchased a new stake in shares of Axon Enterprise during the first quarter worth about $1,110,000. Quotient Wealth Partners LLC bought a new position in Axon Enterprise during the first quarter valued at approximately $438,000. CX Institutional bought a new position in Axon Enterprise during the first quarter valued at approximately $115,000. GAMMA Investing LLC boosted its stake in Axon Enterprise by 11.8% during the first quarter. GAMMA Investing LLC now owns 1,454 shares of the biotechnology company’s stock valued at $765,000 after buying an additional 154 shares during the last quarter. Finally, DAVENPORT & Co LLC boosted its stake in Axon Enterprise by 5.1% during the first quarter. DAVENPORT & Co LLC now owns 940 shares of the biotechnology company’s stock valued at $494,000 after buying an additional 46 shares during the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Analyst Ratings Changes

AXON has been the subject of a number of research reports. Needham & Company LLC set a $870.00 price target on Axon Enterprise and gave the company a “buy” rating in a research note on Tuesday, August 5th. JMP Securities raised their price objective on Axon Enterprise from $725.00 to $825.00 and gave the company a “market outperform” rating in a research note on Tuesday, July 22nd. Bank of America raised their price objective on Axon Enterprise from $895.00 to $1,000.00 and gave the company a “buy” rating in a research note on Wednesday, August 6th. JPMorgan Chase & Co. raised their price objective on Axon Enterprise from $730.00 to $850.00 and gave the company an “overweight” rating in a research note on Thursday, July 17th. Finally, The Goldman Sachs Group raised their price objective on Axon Enterprise from $730.00 to $830.00 and gave the company a “buy” rating in a research note on Wednesday, May 14th. Thirteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, Axon Enterprise has a consensus rating of “Moderate Buy” and an average target price of $837.69.

View Our Latest Report on AXON

Insider Activity

In related news, CAO Jennifer H. Mak sold 75 shares of the firm’s stock in a transaction that occurred on Wednesday, September 3rd. The stock was sold at an average price of $723.50, for a total transaction of $54,262.50. Following the completion of the sale, the chief accounting officer directly owned 15,080 shares of the company’s stock, valued at approximately $10,910,380. This trade represents a 0.49% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, President Joshua Isner sold 15,919 shares of the firm’s stock in a transaction on Friday, August 15th. The stock was sold at an average price of $746.26, for a total value of $11,879,712.94. Following the transaction, the president owned 238,379 shares in the company, valued at $177,892,712.54. The trade was a 6.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 34,865 shares of company stock worth $26,926,433 in the last three months. Corporate insiders own 5.70% of the company’s stock.

Axon Enterprise Price Performance

Shares of AXON stock opened at $728.41 on Monday. Axon Enterprise, Inc has a 52-week low of $346.71 and a 52-week high of $885.91. The company has a debt-to-equity ratio of 0.63, a quick ratio of 2.71 and a current ratio of 2.95. The firm has a market capitalization of $57.18 billion, a P/E ratio of 179.85, a P/E/G ratio of 26.73 and a beta of 1.40. The stock has a 50 day moving average price of $765.93 and a 200 day moving average price of $680.55.

Axon Enterprise (NASDAQ:AXON – Get Free Report) last issued its quarterly earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.54 by $0.58. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The firm had revenue of $668.54 million during the quarter, compared to analyst estimates of $641.77 million. During the same period last year, the company earned $1.20 EPS. Axon Enterprise’s quarterly revenue was up 32.6% compared to the same quarter last year. Axon Enterprise has set its FY 2025 guidance at EPS. As a group, sell-side analysts predict that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

Axon Enterprise Profile

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Recommended Stories

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON – Free Report).